Structure Therapeutics has the potential to have a best-in-class GLP-1 agonist drug for treatment of patients with obesity. Learn more on GPCR stock here.

China's National Health Commission (NHC) published its first set of guidelines to standardise the diagnosis and treatment of ...

Despite the latter overcoming some of the drawbacks of the former, experts say it’s not that simple, or maybe even necessary, ...

BOCA RATON, Fla.–(BUSINESS WIRE)–$VSEE–VSee Health, Inc. (Nasdaq: VSEE), a provider of comprehensive telehealth services that customize workflow streams and ...

A new meta-analysis confirms that semaglutide drugs like Ozempic are not only effective for weight loss, but can also protect ...

America’s obesity rate looks to be plateauing—again.

A new study suggests that GLP-1 agonist medications like Ozempic, which are used for diabetes management and weight loss, may help reduce the risk of overdose and alcohol intoxication in people with ...

The proposal to apply a 10% excise tax on sugary beverages faces opposition from the beverage industry, which argues that the ...

Central and West Warrington PCN implemented a Living Well programme for its population at high risk of cardiovascular disease ...

Han is partnering with former KGI colleague Rachita Sumbria, now an associate professor in Chapman University’s School of Pharmacy, on this research. Han and Sumbria are completing a five-year grant ...

It is common knowledge that obesity, excess sugar and carbohydrate intake as well as sedentary lifestyle increase the risk of ...

Exciting results for MeiraGTx Holdings plc's GAD gene therapy for Parkinson's Disease, with promising phase 1/2 data and ...